glutathione pathway to triple negative cancer NRF2 activation by cysteine as a survival mechanism for triple-negative breast cells Glutathione and Thioredoxin Antioxidant Pathways
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect International Journal of Oncology Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery
Pay in 4 interest-free payments of $7.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



